Biotech

All Articles

GSK falls ph. 2 HPV injection over absence of best-in-class possible

.GSK has actually ditched a stage 2 individual papillomavirus (HPV) injection from its pipeline afte...

OS Therapies refiles $6M IPO to fund HER2 drug, preclinical ADCs

.Operating system Therapies will definitely specify on the NYSE American stock exchange today via a ...

ALX's waning CD47 reaction price delivers sell spiraling down

.ALX Oncology's stage 2 gastric cancer reaction cost has damaged. After viewing its own CD47 blocker...

Ionis axes eye disease coming from targets of Roche-partnered prospect after data disappoint

.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of requir...

Biogen's CEO claimed no risky sell 2023. He prepares to become strong

.While Biogen's pharma peers are hunting for late-stage properties along with little danger, chief e...

Instil refills pipe in $2B biobucks deal with ImmunOnco

.Instil Biography has been a biotech seeking a pipeline after it scrapped its own lead resources ove...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually handed back liberties to a very early Alzheimer's health condition plan to Dena...

Takeda faucets brand-new head of US oncology business-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings...

Vertex, beaten through AATD once more, falls 2 possessions on discard stack

.Vertex's effort to alleviate a rare hereditary health condition has hit yet another problem. The bi...

Vir increases 3 T-cell engagers from Sanofi, lays off 25% of workers

.Vir Biotechnology's second-quarter earnings file wasn't short of significant information. The compa...